張博，中國醫(yī)學科學院北京協(xié)和醫(yī)院，臨床醫(yī)學研究所獨立PI，準聘研究員/博士研究生導師。獲得國家優(yōu)秀青年科學基金（2024），北京市科技新星（2022），北京協(xié)和醫(yī)院中堅骨干人才（2025）等項目資助。博士畢業(yè)于北京大學（醫(yī)學部）藥學院，化學生物學專業(yè)，師從周德敏教授/張禮和院士，2016年入職北京協(xié)和醫(yī)院，醫(yī)學科學研究中心專職科研工作。

長期從事生物技術藥物研究工作，針對目前內(nèi)源性生物大分子在臨床成藥性不足的具體臨床問題，聚焦于生物大分子的精準修飾和人工設計，以及工程化免疫細胞治療技術的基礎研究，探索將其應用于免疫穩(wěn)態(tài)調(diào)控的新策略和新理論發(fā)現(xiàn)。共發(fā)表SCI論文40余篇，其中以第一或通訊作者發(fā)表于Nature BME, 風濕病頂刊Annals of the Rhe Dis, Cell Chem Bio, STTT等國際權(quán)威期刊，申請國家發(fā)明專利13項。主持或作為科技骨干承擔10余項國家和省部級科研課題，包括國自然基金，重大新藥創(chuàng)制專項等。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1.Shengjie Li#, Siyuan Yu#, Mengzhao Wang, Bo Zhang*, Yan Xu*, Synergistic potential of PD-1 blockade and IL-2 in cancer therapy via targeted bi-functional molecule design, Sci Bull (Beijing). 2025 Aug 11:S2095-9273(25)00809-6. (IF = 21.1)

2.Jiaqi Sun#, Lingfeng Guo#, Dezhong Ji#*, Mengfan Yu, Boyang Cheng, Xingxing Zhu, Yeshuang Yuan, Siyu Wu, Yuanjie Zhang, Wen Shi, Zhiqian Chen, Xindang Chu, Jiayu Hu, Liwen Hua, Yiming Wang, Yanning Zhu, Yu Mu, Hanwen Sun, Chuanling Zhang, Qi Wang, Sulong Xiao, Lihe Zhang, Bo Zhang*, Demin Zhou*, Reshape the Fates of Treg and CD8+T Cells Through IL-2Rα by Synergizing Divergent Receptor-Biased IL-2 PEGylates, Adv Sci (Weinh). 2025 May;12(18):e2414931. (IF = 14.9)

3.Bo Zhang#*, Jiaqi Sun#, Yeshuang Yuan#, Dezhong Ji#, Yeting Sun#, Yudong Liu, Shengjie Li, Xingxing Zhu, Xunyao Wu, Jin Hu, Qiu Xie, Ling Wu, Lulu Liu, Boyang Cheng, Yuanjie Zhang, Lingjuan Jiang, Lidan Zhao, Fei Yu, Wei Song, Min Wang, Yue Xu, Shiliang Ma, Yunyun Fe, Lihe Zhang, Demin Zhou*, Xuan Zhang*, Proximity-enabled covalent binding of IL-2 to IL-2Ra selectively activates regulatory T cells and suppresses autoimmunity, Signal Transduction and Targeted Therapy, 2023, 8(1)(28). (IF = 39.3)

4.Yeting Sun#, Yeshuang Yuan, Bo Zhang*, Xuan Zhang*, CARs: a new approach for the treatment of autoimmune diseases, Sci China Life Sci. 2023 Apr;66(4): 711-728. (IF = 9.1)

5.Bo Zhang#, Jiaqi Sun#, Yan Wang#, Dezhong Ji#, Yeshuang Yuan#, Shengjie Li,  Yeting Sun, Yingqin Hou, Pengchong Li, Lidan Zhao, Fei Yu, Wenxiao Ma, Boyang Cheng, Ling Wu, Jin Hu, Min Wang, Wei Song, Xiaogang Li, Hao Li,  Yunyun Fei, Hua Chen, Lihe Zhang, George C. Tsokos*, Demin Zhou*, Xuan Zhang*, Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells, Nature biomedical engineering, 2021, 5(11): 1288-1305. (IF = 25.671)

6.Bo Zhang#,, Yan Wang#,, Yeshuang Yuan#,, Jiaqi Sun, Lulu Liu, Dan Huang, Jin Hu, Min Wang, Shengjie Li, Wei Song, Hua Chen, Demin Zhou*, Xuan Zhang*, In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells, Annals of the Rheumatic Diseases, 2021, 80(2): 176-184. (IF = 19.103)

7.Bo Zhang#, Yan Wang#, Shenlong Huang#, Jiaqi Sun, Min Wang, Wenxiao Ma,  YanboYou, Ling Wu, Jin Hu, Wei Song, Xudong Liu, Shengjie Li, Hua Chen, Guisheng Zhang, Lihe Zhang, Demin Zhou*, Lingjun Li*, Xuan Zhang*, Photoswitchable CAR-T Cell Function In Vitro and In Vivo via a Cleavable Mediator, Cell Chemical biology, 2021, 28(1): 60-69. (IF = 8.116)

8.Yuanyang Guo#, Bo Zhang#, Luying Wang, Shenlong Huang, Shilei Wang, Yanbo You, Gongming Zhu, Anlian Zhu, Mingwei Geng, Lingjun Li*, An efficient and easily-accessible ligand for Cu(I)-catalyzed azide-alkyne cycloaddition bioconjugation, Chem Commun (Camb); 2020 Nov 19;56(92):14401-14403. (IF = 5.996)

9.Bo Zhang#, Qi Yang#, Jingxian Chen, Ling Wu, Tianzhuo Yao, Yiming Wu,  Lihe Zhang, Qing Xia, Demin Zhou*, CRISPRi-Manipulation of Genetic Code Expansion via RF1 for Reassignment of Amber Codon in Bacteria, Sci Rep. 2016 Jan 28:6:20000. (IF = 4.7)

10.Bo Zhang#, Huan Xu, Jingxian Chen, Yongxiang Zheng, Yiming Wu, Longlong Si, Ling Wu, Chuanling Zhang, Gang Xia, Lihe Zhang, Demin Zhou*, Development of next generation of therapeutic IFN-a2b via genetic code, Acta Biomaterialia, 2015, Jun(19): 100-111. (IF = 6.1)